The Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B

Ras mediates cell proliferation, survival and differentiation. Mutations in K-Ras4B are predominant at residues G12, G13 and Q61. Even though all impair GAP-assisted GTP → GDP hydrolysis, the mutation frequencies of K-Ras4B in human cancers vary. Here we aim to figure out their mechanisms and differential oncogenicity. In total, we performed 6.4 μs molecular dynamics simulations on the wild-type K-Ras4B (K-Ras4BWT-GTP/GDP) catalytic domain, the K-Ras4BWT-GTP–GAP complex, and the mutants (K-Ras4BG12C/G12D/G12V-GTP/GDP, K-Ras4BG13D-GTP/GDP, K-Ras4BQ61H-GTP/GDP) and their complexes with GAP. In addition, we simulated ‘exchanged’ nucleotide states. These comprehensive simulations reveal that in solution K-Ras4BWT-GTP exists in two, active and inactive, conformations. Oncogenic mutations differentially elicit an inactive-to-active conformational transition in K-Ras4B-GTP; in K-Ras4BG12C/G12D-GDP they expose the bound nucleotide which facilitates the GDP-to-GTP exchange. These mechanisms may help elucidate the differential mutational statistics in K-Ras4B-driven cancers. Exchanged nucleotide simulations reveal that the conformational transition is more accessible in the GTP-to-GDP than in the GDP-to-GTP exchange. Importantly, GAP not only donates its R789 arginine finger, but stabilizes the catalytically-competent conformation and pre-organizes catalytic residue Q61; mutations disturb the R789/Q61 organization, impairing GAP-mediated GTP hydrolysis. Together, our simulations help provide a mechanistic explanation of key mutational events in one of the most oncogenic proteins in cancer.

[1]  Jacqueline Cherfils,et al.  Regulation of small GTPases by GEFs, GAPs, and GDIs. , 2013, Physiological reviews.

[2]  John C Hunter,et al.  In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C , 2014, Proceedings of the National Academy of Sciences.

[3]  Ruth Nussinov,et al.  GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site* , 2015, The Journal of Biological Chemistry.

[4]  Guido Scarabelli,et al.  Kinesin-5 Allosteric Inhibitors Uncouple the Dynamics of Nucleotide, Microtubule, and Neck-Linker Binding Sites , 2014, Biophysical journal.

[5]  D. Bar-Sagi,et al.  The structural basis for the transition from Ras-GTP to Ras-GDP , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Zoe Cournia,et al.  Investigating the Structure and Dynamics of the PIK3CA Wild-Type and H1047R Oncogenic Mutant , 2014, PLoS Comput. Biol..

[7]  Yalin Zhang,et al.  Insights into the key interactions between human protein phosphatase 5 and cantharidin using molecular dynamics and site-directed mutagenesis bioassays , 2015, Scientific Reports.

[8]  Bernard R Brooks,et al.  Self‐guided Langevin dynamics study of regulatory interactions in NtrC , 2009, Proteins.

[9]  J Andrew McCammon,et al.  Mapping the nucleotide and isoform-dependent structural and dynamical features of Ras proteins. , 2008, Structure.

[10]  Klaus Gerwert,et al.  Ras and GTPase-activating protein (GAP) drive GTP into a precatalytic state as revealed by combining FTIR and biomolecular simulations , 2012, Proceedings of the National Academy of Sciences.

[11]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[12]  T P Straatsma,et al.  The arginine finger of RasGAP helps Gln-61 align the nucleophilic water in GAP-stimulated hydrolysis of GTP , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Maria G Khrenova,et al.  Modeling the role of G12V and G13V Ras mutations in the Ras-GAP-catalyzed hydrolysis reaction of guanosine triphosphate. , 2014, Biochemistry.

[14]  Ruth Nussinov,et al.  Mapping the Conformation Space of Wildtype and Mutant H-Ras with a Memetic, Cellular, and Multiscale Evolutionary Algorithm , 2015, PLoS Comput. Biol..

[15]  Dan Li,et al.  Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations , 2015, Scientific Reports.

[16]  Phillip T. Hawkins,et al.  Crystal Structure and Functional Analysis of Ras Binding to Its Effector Phosphoinositide 3-Kinase γ , 2000, Cell.

[17]  Carla Mattos,et al.  A comprehensive survey of Ras mutations in cancer. , 2012, Cancer research.

[18]  Channing J Der,et al.  KRAS: feeding pancreatic cancer proliferation. , 2014, Trends in biochemical sciences.

[19]  Ralf Janknecht,et al.  Ras/Rap effector specificity determined by charge reversal , 1996, Nature Structural Biology.

[20]  Carla Mattos,et al.  Transformation efficiency of RasQ61 mutants linked to structural features of the switch regions in the presence of Raf. , 2007, Structure.

[21]  Qi Sun,et al.  Discovery of small molecules that bind to K-Ras and inhibit Sos-mediated activation. , 2012, Angewandte Chemie.

[22]  Shuai Li,et al.  The Structural Basis of ATP as an Allosteric Modulator , 2014, PLoS Comput. Biol..

[23]  Lan Huang,et al.  Structural basis for the interaction of Ras with RaIGDS , 1998, Nature Structural Biology.

[24]  Suryani Lukman,et al.  The Distinct Conformational Dynamics of K-Ras and H-Ras A59G , 2010, PLoS Comput. Biol..

[25]  Ulrich H E Hansmann,et al.  Stability of Iowa mutant and wild type Aβ-peptide aggregates. , 2014, The Journal of chemical physics.

[26]  Ozlem Keskin,et al.  GTP-Dependent K-Ras Dimerization. , 2015, Structure.

[27]  Mitsuhiko Ikura,et al.  NMR-based functional profiling of RASopathies and oncogenic RAS mutations , 2013, Proceedings of the National Academy of Sciences.

[28]  Tyler J. Glembo,et al.  The Role of Conformational Dynamics and Allostery in the Disease Development of Human Ferritin. , 2015, Biophysical journal.

[29]  R. E. Salmas,et al.  Investigation of Inhibition Mechanism of Chemokine Receptor CCR5 by Micro-second Molecular Dynamics Simulations , 2015, Scientific Reports.

[30]  R. Nussinov,et al.  The structural basis for cancer treatment decisions , 2014, Oncotarget.

[31]  Kevan M. Shokat,et al.  K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions , 2013, Nature.

[32]  S H Kim,et al.  Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. , 1992, Science.

[33]  Shaoyong Lu,et al.  Harnessing Allostery: A Novel Approach to Drug Discovery , 2014, Medicinal research reviews.

[34]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[35]  J. Downward.  RAS's cloak of invincibility slips at last? , 2014, Cancer cell.

[36]  Francesca Fanelli,et al.  Nucleotide Binding Switches the Information Flow in Ras GTPases , 2011, PLoS Comput. Biol..

[37]  Ruth Nussinov,et al.  High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site , 2015, Biophysical journal.

[38]  R. Nussinov,et al.  Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD. , 2015, Structure.

[39]  Ruth Nussinov,et al.  A New View of Ras Isoforms in Cancers. , 2016, Cancer research.

[40]  Y. Yoshikawa,et al.  Solution Structure of the State 1 Conformer of GTP-bound H-Ras Protein and Distinct Dynamic Properties between the State 1 and State 2 Conformers* , 2011, The Journal of Biological Chemistry.

[41]  Ruth Nussinov,et al.  The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding. , 2016, Current opinion in structural biology.

[42]  T P Straatsma,et al.  Revisiting the structural flexibility of the complex p21ras‐GTP: The catalytic conformation of the molecular switch II , 2001, Proteins.

[43]  Ruth Nussinov,et al.  Inhibitors of Ras–SOS Interactions , 2016, ChemMedChem.

[44]  Tingjun Hou,et al.  P-loop Conformation Governed Crizotinib Resistance in G2032R-Mutated ROS1 Tyrosine Kinase: Clues from Free Energy Landscape , 2014, PLoS Comput. Biol..

[45]  Holger Sondermann,et al.  Structural Analysis of Autoinhibition in the Ras Activator Son of Sevenless , 2004, Cell.

[46]  P. Hawkins,et al.  Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. , 2000, Cell.

[47]  Alex Travesset,et al.  Differential dynamics of RAS isoforms in GDP‐ and GTP‐bound states , 2015, Proteins.

[48]  R. Nussinov,et al.  Mechanisms of Membrane Binding of Small GTPase K-Ras4B Farnesylated Hypervariable Region* , 2015, The Journal of Biological Chemistry.

[49]  R. Nussinov,et al.  The free energy landscape in translational science: how can somatic mutations result in constitutive oncogenic activation? , 2014, Physical chemistry chemical physics : PCCP.

[50]  M Karplus,et al.  Molecular switch in signal transduction: reaction paths of the conformational changes in ras p21. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Ozlem Keskin,et al.  Ras Conformational Ensembles, Allostery, and Signaling. , 2016, Chemical reviews.

[52]  Viktor Hornak,et al.  Structure of a transient intermediate for GTP hydrolysis by ras. , 2006, Structure.

[53]  I. Mellman,et al.  Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity , 2012, Proceedings of the National Academy of Sciences.

[54]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[55]  Takashi Kumasaka,et al.  Structural Basis for Conformational Dynamics of GTP-bound Ras Protein* , 2010, The Journal of Biological Chemistry.

[56]  Shaoyong Lu,et al.  ASBench: benchmarking sets for allosteric discovery , 2015, Bioinform..

[57]  Ruth Nussinov,et al.  The Mechanism of ATP-Dependent Allosteric Protection of Akt Kinase Phosphorylation. , 2015, Structure.

[58]  Roland Seifert,et al.  Faculty Opinions recommendation of K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. , 2013 .

[59]  James Andrew McCammon,et al.  Ras Conformational Switching: Simulating Nucleotide-Dependent Conformational Transitions with Accelerated Molecular Dynamics , 2009, PLoS Comput. Biol..

[60]  Gennady Verkhivker,et al.  Computational Modeling of Allosteric Regulation in the Hsp90 Chaperones: A Statistical Ensemble Analysis of Protein Structure Networks and Allosteric Communications , 2014, PLoS Comput. Biol..

[61]  W. Kabsch,et al.  The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. , 1997, Science.

[62]  Ruth Nussinov,et al.  The higher level of complexity of K‐Ras4B activation at the membrane , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[63]  A. Warshel,et al.  On the mechanism of guanosine triphosphate hydrolysis in ras p21 proteins. , 1992, Biochemistry.

[64]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[65]  A. Wittinghofer,et al.  The GAP arginine finger movement into the catalytic site of Ras increases the activation entropy , 2008, Proceedings of the National Academy of Sciences.

[66]  Jay T. Groves,et al.  Ras activation by SOS: Allosteric regulation by altered fluctuation dynamics , 2014, Science.

[67]  Philipp M. Cromm,et al.  Small-molecule modulation of Ras signaling. , 2014, Nature chemical biology.

[68]  S. Fesik,et al.  Drugging the undruggable RAS: Mission Possible? , 2014, Nature Reviews Drug Discovery.

[69]  Kresten Lindorff-Larsen,et al.  Communication Routes in ARID Domains between Distal Residues in Helix 5 and the DNA-Binding Loops , 2014, PLoS Comput. Biol..